Literature DB >> 21498612

Reticular drusen associated with geographic atrophy in age-related macular degeneration.

Steffen Schmitz-Valckenberg1, Florian Alten, Julia S Steinberg, Glenn J Jaffe, Monika Fleckenstein, Bickol N Mukesh, Thomas C Hohman, Frank G Holz.   

Abstract

PURPOSE: To characterize reticular drusen (RDR) in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in a prospective, multicenter, natural history study.
METHODS: Confocal scanning laser ophthalmoscopy (cSLO) three-field fundus autofluorescence (FAF; exc., 488; em., 500-700 nm), near-infrared reflectance (IR; 820 nm), and blue reflectance (BR; 488 nm) images as well as red-free (RF) and color fundus (CF) camera photographs were recorded in 458 GA patients. The digital images were evaluated by two independent readers with subsequent senior reader arbitration for prevalence and topographic distribution of RDR using a modified Early Treatment Diabetic Retinopathy Study grid.
RESULTS: RDR were detected with at least one cSLO modality in 286 of 458 (62%) patients in either eye (bilateral 207 [45%]) and were visible in fundus camera photographs in 66 of 371 (18%) patients (bilateral 48 [13%]). Prevalence of RDR by cSLO imaging was associated with increasing age (P = 0.007) and female sex (P = 0.007), but not with GA total lesion area (P = 0.38). Cohen kappa statistics showed good interobserver agreement for FAF (0.81) and IR (0.82) imaging modes, and moderate agreement was found for BR (0.48), RF (0.48), and CF (0.40). On three-field FAF images RDR were present most frequently superior to the fovea (99%).
CONCLUSIONS: RDR represent a common phenotypic hallmark in GA eyes. RDR are readily identified using cSLO imaging technology. These observations may explain the high prevalence determined herein, in contrast to previous reports based on fundus photographs. Incorporation of these novel imaging modalities in future natural history studies may facilitate efforts aimed at defining the role and predictive value of RDR in the progression of AMD. (ClinicalTrials.gov number, NCT00599846.)

Entities:  

Mesh:

Year:  2011        PMID: 21498612     DOI: 10.1167/iovs.11-7235

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  65 in total

1.  Microstructure of subretinal drusenoid deposits revealed by adaptive optics imaging.

Authors:  Alexander Meadway; Xiaolin Wang; Christine A Curcio; Yuhua Zhang
Journal:  Biomed Opt Express       Date:  2014-02-12       Impact factor: 3.732

2.  ASSOCIATION BETWEEN VISUAL FUNCTION AND SUBRETINAL DRUSENOID DEPOSITS IN NORMAL AND EARLY AGE-RELATED MACULAR DEGENERATION EYES.

Authors:  David Neely; Anna V Zarubina; Mark E Clark; Carrie E Huisingh; Gregory R Jackson; Yuhua Zhang; Gerald McGwin; Christine A Curcio; Cynthia Owsley
Journal:  Retina       Date:  2017-07       Impact factor: 4.256

3.  Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy.

Authors:  Soo-Young Kim; Hyun-Jin Yang; Yi-Sheng Chang; Jung-Woong Kim; Matthew Brooks; Emily Y Chew; Wai T Wong; Robert N Fariss; Rivka A Rachel; Tiziana Cogliati; Haohua Qian; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 4.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

5.  Changes in reticular pseudodrusen area in eyes that progressed from early to late age-related macular degeneration.

Authors:  Patrick A Kaszubski; Tal Ben Ami; Céline Saade; Camellia Nabati; Vivek Kumar; Ana Rita Santos; Rufino Silva; Maria Luz Cachulo; José G Cunha-Vaz; R Theodore Smith
Journal:  Int Ophthalmol       Date:  2017-03-07       Impact factor: 2.031

6.  [Reticular drusen over time with SD-OCT].

Authors:  J Auge; J S Steinberg; M Fleckenstein; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

7.  Characterisation of reticular pseudodrusen and their central target aspect in multi-spectral, confocal scanning laser ophthalmoscopy.

Authors:  F Alten; C R Clemens; P Heiduschka; N Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-26       Impact factor: 3.117

8.  Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps.

Authors:  Paulina Haas; Marieh Esmaeelpour; Siamak Ansari-Shahrezaei; Wolfgang Drexler; Susanne Binder
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-25       Impact factor: 4.799

9.  DYNAMISM OF DOT SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION DEMONSTRATED WITH ADAPTIVE OPTICS IMAGING.

Authors:  Yuhua Zhang; Xiaolin Wang; Pooja Godara; Tianjiao Zhang; Mark E Clark; C Douglas Witherspoon; Richard F Spaide; Cynthia Owsley; Christine A Curcio
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

10.  Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.

Authors:  Amitha Domalpally; Elvira Agrón; Jeong W Pak; Tiarnan D Keenan; Fredrick L Ferris; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2019-07-29       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.